Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitor as an Add-on Drug to GLP-1 Receptor Agonists for Glycemic Control of a Patient with Prader–Willi Syndrome: A Case Report

INTRODUCTION: Diabetes patients with Prader–Willi syndrome (PWS) are obese because of hyperphagia; weight control by dietary modification and medicine is required for glycemic control. There are several recent reports showing the effectiveness of GLP-1 receptor agonists (GLP-1RAs) for diabetes treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Horikawa, Yukio, Enya, Mayumi, Komagata, Makie, Hashimoto, Ken-ichi, Kagami, Masayo, Fukami, Maki, Takeda, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5801255/
https://www.ncbi.nlm.nih.gov/pubmed/29335890
http://dx.doi.org/10.1007/s13300-018-0369-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5801255/
https://www.ncbi.nlm.nih.gov/pubmed/29335890
http://dx.doi.org/10.1007/s13300-018-0369-5

Ejemplares similares